VanEck Biotech Financials
| BBH Etf | MXN 2,248 0.00 0.00% |
VanEck |
The data published in VanEck Biotech's official financial statements typically reflect VanEck Biotech's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving VanEck Biotech's quantitative information. For example, before you start analyzing numbers published by VanEck accountants, it's essential to understand VanEck Biotech's liquidity, profitability, and earnings quality within the context of the Market Vectors space in which it operates.
Please note, the imprecision that can be found in VanEck Biotech's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of VanEck Biotech ETF. Check VanEck Biotech's Beneish M Score to see the likelihood of VanEck Biotech's management manipulating its earnings.
| Instrument | Mexico Etf |
| Exchange | Mexican Exchange |
| Region | Others |
| Investment Issuer | Others |
| Etf Family | Market Vectors |
| Fund Category | Others |
| Portfolio Concentration | Others |
| Benchmark | Dow Jones Industrial |
| Phone | 888 658 8287 |
| Currency | MXN - Mexican Peso |
VanEck Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining VanEck Biotech's current stock value. Our valuation model uses many indicators to compare VanEck Biotech value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across VanEck Biotech competition to find correlations between indicators driving VanEck Biotech's intrinsic value. More Info.VanEck Biotech ETF is rated below average in price to earning as compared to similar ETFs. It is fourth largest ETF in price to book as compared to similar ETFs fabricating about 0.17 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for VanEck Biotech ETF is roughly 6.06 . Comparative valuation analysis is a catch-all model that can be used if you cannot value VanEck Biotech by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for VanEck Biotech's Etf. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.VanEck Biotech ETF Systematic Risk
VanEck Biotech's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. VanEck Biotech volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on VanEck Biotech ETF correlated with the market. If Beta is less than 0 VanEck Biotech generally moves in the opposite direction as compared to the market. If VanEck Biotech Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one VanEck Biotech ETF is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of VanEck Biotech is generally in the same direction as the market. If Beta > 1 VanEck Biotech moves generally in the same direction as, but more than the movement of the benchmark.
Additional Information and Resources on Investing in VanEck Etf
When determining whether VanEck Biotech ETF offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of VanEck Biotech's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Vaneck Biotech Etf. Outlined below are crucial reports that will aid in making a well-informed decision on Vaneck Biotech Etf:Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in VanEck Biotech ETF. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.